Trending
- The National Cancer Plan promises a bold vision – now to make it a reality – Cancer Research UK
- How KRAS G12C Data Should Shape Combination Trial Design
- Taxane-induced conformational changes in the microtubule lattice activate GEF-H1-dependent RhoA signalling
- Why Gilead can’t stop talking about its ambitions in immunology
- Emerging Endocrine Doublets and Serial ESR1 Testing in HR+/HER2− mBC
- The Case for Frontline Zongertinib in HER2-Mutant NSCLC
- Acting on a HER2 Result and Navigating Access to Therapy
- What’s next for liquid biopsy in cancer diagnosis and treatment? – Cancer Research UK
Thursday, September 24